No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples

Fiona Crawford, Melissa Freeman, Terrence Town, Daniele Daniele Fallin, Michael Gold, Ranjan Duara, Mike Mullan

Research output: Contribution to journalArticle

Abstract

Mutations in the tau protein gene have recently been found to cause familial fronto-temporal dementia in a number of kindreds demonstrating linkage to chromosome 17. Given that tau pathology is a hallmark of Alzheimer's disease (AD), this raises the possibility that mutations in tau may also be associated with AD. We have investigated the allelic frequencies of polymorphisms in the Tau gene for a possible allelic distortion in Alzheimer's cases, which might suggest a conferred genetic risk. We have genotyped 65 community-based and 200 clinic-based AD cases, and 142 community-based controls at the Tau exon 6 AflIII and BslI polymorphisms and find no independent association with risk for AD in these samples. Further analysis including APOE genotypes from the same samples demonstrated no interaction between either of these polymorphisms and APOE in conferring risk for AD. In addition, haplotype analysis across both sites revealed no difference in haplotype frequencies between cases and controls, nor any interaction with APOE. Therefore our data do not suggest any association between these variations in the Tau gene and Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)193-196
Number of pages4
JournalNeuroscience Letters
Volume266
Issue number3
DOIs
StatePublished - May 14 1999
Externally publishedYes

Fingerprint

Alzheimer Disease
Population
Genes
Haplotypes
tau Proteins
Chromosomes, Human, Pair 17
Mutation
Dementia
Exons
Genotype
Pathology

Keywords

  • Alzheimer's disease
  • Frontotemporal dementia with Parkinsons
  • Genetic association
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples. / Crawford, Fiona; Freeman, Melissa; Town, Terrence; Fallin, Daniele Daniele; Gold, Michael; Duara, Ranjan; Mullan, Mike.

In: Neuroscience Letters, Vol. 266, No. 3, 14.05.1999, p. 193-196.

Research output: Contribution to journalArticle

Crawford, Fiona ; Freeman, Melissa ; Town, Terrence ; Fallin, Daniele Daniele ; Gold, Michael ; Duara, Ranjan ; Mullan, Mike. / No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples. In: Neuroscience Letters. 1999 ; Vol. 266, No. 3. pp. 193-196.
@article{5240edb68fcc4f6dbae4eaf30d3de62f,
title = "No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples",
abstract = "Mutations in the tau protein gene have recently been found to cause familial fronto-temporal dementia in a number of kindreds demonstrating linkage to chromosome 17. Given that tau pathology is a hallmark of Alzheimer's disease (AD), this raises the possibility that mutations in tau may also be associated with AD. We have investigated the allelic frequencies of polymorphisms in the Tau gene for a possible allelic distortion in Alzheimer's cases, which might suggest a conferred genetic risk. We have genotyped 65 community-based and 200 clinic-based AD cases, and 142 community-based controls at the Tau exon 6 AflIII and BslI polymorphisms and find no independent association with risk for AD in these samples. Further analysis including APOE genotypes from the same samples demonstrated no interaction between either of these polymorphisms and APOE in conferring risk for AD. In addition, haplotype analysis across both sites revealed no difference in haplotype frequencies between cases and controls, nor any interaction with APOE. Therefore our data do not suggest any association between these variations in the Tau gene and Alzheimer's disease.",
keywords = "Alzheimer's disease, Frontotemporal dementia with Parkinsons, Genetic association, Tau",
author = "Fiona Crawford and Melissa Freeman and Terrence Town and Fallin, {Daniele Daniele} and Michael Gold and Ranjan Duara and Mike Mullan",
year = "1999",
month = "5",
day = "14",
doi = "10.1016/S0304-3940(99)00303-1",
language = "English (US)",
volume = "266",
pages = "193--196",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples

AU - Crawford, Fiona

AU - Freeman, Melissa

AU - Town, Terrence

AU - Fallin, Daniele Daniele

AU - Gold, Michael

AU - Duara, Ranjan

AU - Mullan, Mike

PY - 1999/5/14

Y1 - 1999/5/14

N2 - Mutations in the tau protein gene have recently been found to cause familial fronto-temporal dementia in a number of kindreds demonstrating linkage to chromosome 17. Given that tau pathology is a hallmark of Alzheimer's disease (AD), this raises the possibility that mutations in tau may also be associated with AD. We have investigated the allelic frequencies of polymorphisms in the Tau gene for a possible allelic distortion in Alzheimer's cases, which might suggest a conferred genetic risk. We have genotyped 65 community-based and 200 clinic-based AD cases, and 142 community-based controls at the Tau exon 6 AflIII and BslI polymorphisms and find no independent association with risk for AD in these samples. Further analysis including APOE genotypes from the same samples demonstrated no interaction between either of these polymorphisms and APOE in conferring risk for AD. In addition, haplotype analysis across both sites revealed no difference in haplotype frequencies between cases and controls, nor any interaction with APOE. Therefore our data do not suggest any association between these variations in the Tau gene and Alzheimer's disease.

AB - Mutations in the tau protein gene have recently been found to cause familial fronto-temporal dementia in a number of kindreds demonstrating linkage to chromosome 17. Given that tau pathology is a hallmark of Alzheimer's disease (AD), this raises the possibility that mutations in tau may also be associated with AD. We have investigated the allelic frequencies of polymorphisms in the Tau gene for a possible allelic distortion in Alzheimer's cases, which might suggest a conferred genetic risk. We have genotyped 65 community-based and 200 clinic-based AD cases, and 142 community-based controls at the Tau exon 6 AflIII and BslI polymorphisms and find no independent association with risk for AD in these samples. Further analysis including APOE genotypes from the same samples demonstrated no interaction between either of these polymorphisms and APOE in conferring risk for AD. In addition, haplotype analysis across both sites revealed no difference in haplotype frequencies between cases and controls, nor any interaction with APOE. Therefore our data do not suggest any association between these variations in the Tau gene and Alzheimer's disease.

KW - Alzheimer's disease

KW - Frontotemporal dementia with Parkinsons

KW - Genetic association

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=0033553641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033553641&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(99)00303-1

DO - 10.1016/S0304-3940(99)00303-1

M3 - Article

C2 - 10465706

AN - SCOPUS:0033553641

VL - 266

SP - 193

EP - 196

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -